Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309187811> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4309187811 endingPage "C082" @default.
- W4309187811 startingPage "C082" @default.
- W4309187811 abstract "Abstract Macrophages can be repolarized to promote tumor destruction, particularly by triggering tumoricidal phagocytosis of cancer cells. Despite the increasing interest in monoclonal antibody therapies targeting tumor antigens to drive cancer cell elimination via phagocidal macrophages, we still face tremendous challenges in developing adequate therapeutics due to lack of knowledge of the signaling pathways that induce phagocidal macrophages. Our previous work showed that cIAP1/2 antagonism and T cell derived cytokines promote anti-tumor immunity by reprogramming tumoricidal macrophages to phagocytose both live and dead tumor cells. Here we performed transcriptional analysis on both macrophages and tumor cells treated with cIAP1/2 antagonism or vehicle and identified candidate positive and negative regulators of phagocytosis. We are demonstrating how these receptors-ligand pairs on macrophages and tumor cells are induced and the mechanisms by which they effect tumor cell destruction. We also performed an in vitro CRISPR screen on tumor cells cocultured with macrophages, treated with cIAP1/2 antagonism or vehicle, recovered the DNA of phagocytosed tumor cells from within macrophages and compared to non-phagocytosed tumor cells to discover mediators of resistance or sensitivity to both baseline phagocytosis (efferocytosis) and cIAP1/2 antagonism induced phagocytosis.Our screen revealed a striking lack of dependence on MHC class I for tumors treated in vivo. Genes involved in phagocytosis resistance instead converged on regulation of the cytoskeleton and the tumor suppressor gene Stk11. This study will provide critical insights on tumoricidal macrophages, uncover the key pathways reprogramming these myeloid cells, and decipher the essential tumor-intrinsic pathways resulting in sensitivity and resistance to anti-tumor phagocytosis. Citation Format: Li Qiang, Samantha Liu, Gabrielle Ro, Lestat Ali, Patrick Lenehan, Felix Hambizer, Michael Dougan, Stephanie Dougan. Signaling pathways inducing tumoricidal phagocytosis in pancreatic cancer [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer; 2022 Sep 13-16; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2022;82(22 Suppl):Abstract nr C082." @default.
- W4309187811 created "2022-11-24" @default.
- W4309187811 creator A5001285437 @default.
- W4309187811 creator A5008839380 @default.
- W4309187811 creator A5027434695 @default.
- W4309187811 creator A5032454325 @default.
- W4309187811 creator A5038863792 @default.
- W4309187811 creator A5041054069 @default.
- W4309187811 creator A5043698578 @default.
- W4309187811 creator A5085159591 @default.
- W4309187811 date "2022-11-15" @default.
- W4309187811 modified "2023-09-30" @default.
- W4309187811 title "Abstract C082: Signaling pathways inducing tumoricidal phagocytosis in pancreatic cancer" @default.
- W4309187811 doi "https://doi.org/10.1158/1538-7445.panca22-c082" @default.
- W4309187811 hasPublicationYear "2022" @default.
- W4309187811 type Work @default.
- W4309187811 citedByCount "0" @default.
- W4309187811 crossrefType "journal-article" @default.
- W4309187811 hasAuthorship W4309187811A5001285437 @default.
- W4309187811 hasAuthorship W4309187811A5008839380 @default.
- W4309187811 hasAuthorship W4309187811A5027434695 @default.
- W4309187811 hasAuthorship W4309187811A5032454325 @default.
- W4309187811 hasAuthorship W4309187811A5038863792 @default.
- W4309187811 hasAuthorship W4309187811A5041054069 @default.
- W4309187811 hasAuthorship W4309187811A5043698578 @default.
- W4309187811 hasAuthorship W4309187811A5085159591 @default.
- W4309187811 hasConcept C121608353 @default.
- W4309187811 hasConcept C1491633281 @default.
- W4309187811 hasConcept C160448771 @default.
- W4309187811 hasConcept C202751555 @default.
- W4309187811 hasConcept C203014093 @default.
- W4309187811 hasConcept C2779244956 @default.
- W4309187811 hasConcept C502942594 @default.
- W4309187811 hasConcept C54355233 @default.
- W4309187811 hasConcept C55493867 @default.
- W4309187811 hasConcept C77255625 @default.
- W4309187811 hasConcept C86803240 @default.
- W4309187811 hasConcept C95444343 @default.
- W4309187811 hasConcept C96232424 @default.
- W4309187811 hasConceptScore W4309187811C121608353 @default.
- W4309187811 hasConceptScore W4309187811C1491633281 @default.
- W4309187811 hasConceptScore W4309187811C160448771 @default.
- W4309187811 hasConceptScore W4309187811C202751555 @default.
- W4309187811 hasConceptScore W4309187811C203014093 @default.
- W4309187811 hasConceptScore W4309187811C2779244956 @default.
- W4309187811 hasConceptScore W4309187811C502942594 @default.
- W4309187811 hasConceptScore W4309187811C54355233 @default.
- W4309187811 hasConceptScore W4309187811C55493867 @default.
- W4309187811 hasConceptScore W4309187811C77255625 @default.
- W4309187811 hasConceptScore W4309187811C86803240 @default.
- W4309187811 hasConceptScore W4309187811C95444343 @default.
- W4309187811 hasConceptScore W4309187811C96232424 @default.
- W4309187811 hasIssue "22_Supplement" @default.
- W4309187811 hasLocation W43091878111 @default.
- W4309187811 hasOpenAccess W4309187811 @default.
- W4309187811 hasPrimaryLocation W43091878111 @default.
- W4309187811 hasRelatedWork W1969752809 @default.
- W4309187811 hasRelatedWork W2025264984 @default.
- W4309187811 hasRelatedWork W2030131753 @default.
- W4309187811 hasRelatedWork W2233236770 @default.
- W4309187811 hasRelatedWork W2359425528 @default.
- W4309187811 hasRelatedWork W2378785636 @default.
- W4309187811 hasRelatedWork W2984552443 @default.
- W4309187811 hasRelatedWork W3023202684 @default.
- W4309187811 hasRelatedWork W3149366977 @default.
- W4309187811 hasRelatedWork W4220851646 @default.
- W4309187811 hasVolume "82" @default.
- W4309187811 isParatext "false" @default.
- W4309187811 isRetracted "false" @default.
- W4309187811 workType "article" @default.